In stock
Fludarabine Phosphate Neapolis Vial 2 ml
In stock
Only 1 left
SKU
10331015086
Fludarabine Phosphate Neapolis Vial is an antineoplastic medication used primarily for the treatment of chronic lymphocytic leukemia (CLL). This prescription drug, administered intravenously, works by inhibiting the growth of cancer cells. It is intended for use under strict medical supervision due to its potent therapeutic effects and potential side effects.
Product Overview
Fludarabine Phosphate Neapolis is an antineoplastic medication indicated for the treatment of certain types of cancer, primarily chronic lymphocytic leukemia (CLL).
It belongs to a class of drugs known as purine analogs, which work by interfering with DNA synthesis, thereby inhibiting the growth of cancer cells.
This medication is administered under the supervision of a qualified healthcare professional in a hospital or clinical setting.
Its therapeutic action targets rapidly dividing cells, making it effective against various hematologic malignancies.
Benefits of Use
- Effective treatment for chronic lymphocytic leukemia (CLL).
- Can be used as monotherapy or in combination with other chemotherapeutic agents.
- Helps to reduce the progression of cancer and improve patient outcomes in selected cases.
How to Use
- Fludarabine Phosphate Neapolis is for intravenous administration only.
- The dosage and administration schedule are determined by a physician based on the patient's condition, body surface area, and specific cancer type.
- The drug is typically diluted in a suitable intravenous solution (e.g., 0.9% sodium chloride) prior to infusion.
- Administer the infusion slowly over a specified period, as directed by the healthcare provider.
- Adhere strictly to aseptic techniques during preparation and administration.
Caution & Warnings
- Severe Myelosuppression: May cause severe bone marrow suppression, leading to anemia, neutropenia, and thrombocytopenia. Regular blood counts are essential.
- Immunosuppression: Patients are at increased risk of infections, including opportunistic infections.
- Neurotoxicity: Can cause severe neurological effects, including vision disturbances, confusion, and seizures.
- Tumor Lysis Syndrome: Risk of tumor lysis syndrome, especially in patients with a large tumor burden.
- Renal and Hepatic Impairment: Use with caution and dose adjustment may be necessary in patients with kidney or liver dysfunction.
- Pregnancy and Lactation: Contraindicated during pregnancy and breastfeeding due to potential fetal harm. Effective contraception is required during and after treatment.
- Handling Precautions: Must be handled by trained personnel using appropriate protective equipment due to its cytotoxic nature.
Ingredients
Each 2 ml vial contains:
- Fludarabine Phosphate (as the active ingredient).
- Other inactive ingredients may include mannitol, sodium hydroxide, and water for injection (specific excipients vary by manufacturer).
Product Details
- Form: Solution for Injection
- Strength: 50 mg Fludarabine Phosphate per 2 ml vial
- Administration Route: Intravenous
- Manufacturer: Neapolis Pharma
- Drug Type: Prescription only (Chemotherapeutic agent)
| Gtin | 1408245767 |
|---|---|
| Recommended Sale Price | 161.05 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | FLUDARABINE PHOSPHATE |
| SFDA Reg. No | 1408245767 |
| IBC | 1408245767 |
| Drug Type | Prescription only |
| Scientific Name | Fludarabine Phosphate |
| Strength | 50 mg |
| Strength Unit | mg |
| Form | Solution for Injection |
| Admin Route | Intravenous |
| Size | 2 ml |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 2 ml |
| Storage conditions | Store below 25°C, protect from light |
| Refrigerator Storage | No |
Products you might like
